---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-117462"
form_type: "8-K"
ticker: null
cik: "0001850079"
company_name: "Telesis Bio Inc."
filed_at: "2024-10-25T23:59:59+00:00"
generated_at: "2026-05-30T10:07:53.922249+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Telesis Bio CLO Robert H. Cutler to depart Oct 31; severance of $307,500 with acceleration clause

## Summary
- CLO Robert H. Cutler departs effective Oct 31, 2024; may enter consulting agreement for transition.
- Severance of $307,500 (9 months salary) paid in installments; accelerated if company raises $4M.
- Company to pay $23,596.88 for nine months of COBRA premiums.
- Cutler signs general release in favor of the company.

## SEC filing metadata
- accession: 0000950170-24-117462
- form_type: 8-K
- cik: 0001850079
- company_name: Telesis Bio Inc.
- filed_at: 2024-10-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850079/000095017024117462/0000950170-24-117462-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850079/000095017024117462/tbio-20241021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-117462
- JSON: https://secwatch.observer/filing/0000950170-24-117462.json
- Plain text: https://secwatch.observer/filing/0000950170-24-117462.txt

## Key facts
- Executive change
  Robert H. Cutler departed as Chief Legal Officer at Telesis Bio Inc..
  - Action: will depart
  - Role: Chief Legal Officer
  source text: Telesis Bio Inc. (the "Company") announced that effective October 31, 2024, Robert H. Cutler, the Company's Chief Legal Officer, will depart the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850079/000095017024117462/0000950170-24-117462-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.